397 results on '"Villa, Chet"'
Search Results
2. Impact of inflammation and steroids on anti-coagulation in children supported on a ventricular assist device
3. Deep Learning for Automated Measurement of Total Cardiac Volume for Heart Transplantation Size Matching
4. ACTION-ARC Pediatric and Adult Congenital Heart Disease Ventricular Assist Device Adverse Event Definitions-2023
5. Device Innovations in Pediatric Heart Failure
6. Left Atrial Phasic Function via Cardiac Magnetic Resonance Imaging in Patients with Duchenne Muscular Dystrophy
7. Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV
8. In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
9. Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant
10. School age and adolescent heart failure following the Norwood procedure
11. Multicenter outcomes for ventricular assist device support for failed stage II palliation
12. Abstract 14448: Graft Loss and Rejection Following COVID in Pediatric Heart Transplantation - A Pediatric Heart Transplant Society (PHTS) Propensity Matched Analysis
13. Abstract 13631: Desmoplakin Cardiomyopathy in Pediatric Patients - A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy
14. Single Center Experience With Durable Continuous Flow Single Ventricle Assist Device: A Viable Option in Fontan Circulatory Failure
15. Decreased Risk of Strokes in Children with Ventricular Assist Devices Within ACTION
16. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION
17. Diversity of Dystrophin Gene Mutations and Disease Progression in a Contemporary Cohort of Duchenne Muscular Dystrophy
18. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease
19. Cardiac atrial pathology in Duchenne muscular dystrophy
20. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
21. A novel method of donor‒recipient size matching in pediatric heart transplantation: A total cardiac volume‒predictive model
22. Abstract 11615: The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy
23. Destination-Therapy Ventricular Assist Device in Children: “The Future Is Now”
24. Deep Learning for Automated Measurement of Total Cardiac Volume for Heart Transplantation Size Matching
25. Implantable Cardioverter Defibrillator Use in Males with Duchenne Muscular Dystrophy and Severe Left Ventricular Dysfunction
26. Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy
27. Hemodynamic Response to Device Titration in the Shunted Single Ventricle Circulation: A Patient Cohort Modeling Study
28. Use of advanced heart failure therapies in Duchenne muscular dystrophy
29. School age and adolescent heart failure following the Norwood procedure
30. Pediatric Mechanical Circulatory Support
31. The Berlin Heart EXCOR Experience in the USA
32. Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial
33. Utilization of VADs in children with restrictive and hypertrophic cardiomyopathy: Are we there yet?
34. Outcomes of children supported with devices labeled as “temporary” or short term: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support
35. Optimizing surgical placement of the HeartWare ventricular assist device in children and adolescents by virtual implantation
36. Pediatric ventricular assist device simulation: Constructing an in situ simulation training program to facilitate education and competency
37. Reversal of Amyloid-Induced Heart Disease in Desmin-Related Cardiomyopathy
38. Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant
39. In the era of outpatient ventricular assist devices, is it time to reconsider the practice of bridging older children to transplant on outpatient inotropes?
40. Does Small Size Matter With Continuous Flow Devices?: Analysis of the INTERMACS Database of Adults With BSA ≤1.5 m2
41. Abstract 13291: Impact of VAD Support Duration on Pediatric Heart Transplant Outcomes
42. Left Ventricular Magnetic Resonance Imaging Strain Predicts the Onset of Duchenne Muscular Dystrophy–Associated Cardiomyopathy
43. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy
44. Optimizing Postcardiac Transplantation Outcomes in Children with Ventricular Assist Devices: How Long Should the Bridge Be?
45. The Creation of a Pediatric Health Care Learning Network: The ACTION Quality Improvement Collaborative
46. Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy
47. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C
48. Echocardiography Provides a Reliable Estimate of Total Cardiac Volume for Pediatric Heart Transplantation
49. Initial multicenter experience with ventricular assist devices in children and young adults with muscular dystrophy: An ACTION registry analysis
50. Dystrophin Genotype–Cardiac Phenotype Correlations in Duchenne and Becker Muscular Dystrophies Using Cardiac Magnetic Resonance Imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.